Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats

Badkook Maha

doi:doi:10.11648/j.ajbls.20130101.11

| Peer-Reviewed

Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats

Badkook Maha

Published in American Journal of Biomedical and Life Sciences (Volume 1, Issue 1)

Received: 26 April 2013 Published: 30 May 2013

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Purpose: To investigate the effect of turmeric supplement (T), fermented milk with Probiotic strain Bifidobacterium lactis DN-173 010 (P), a combination of (T+P) on glycemia, lipidemia, and oxidative status in streptozotocin–induced diabetic rats.Materials and methods: Thirty male albino diabetic rats were fed a normal diet and divided to groups (n=6/group) according to the following treatments for 45 days: Turmeric (T) (225mg/kg/d), fermented milk Probiotics (P) (0.5ml/kg/d), Turmeric-Probiotics combination (T+ P) (225mg/kg/d + 0.5ml/kg/d), Oral hypoglycemic agent (OHA) (0.5 ml of glibenclamide; 450 µg/kg/day), and non-treated (DM). Blood glucose and glycayted hemoglobin were determined after diabetes induction and at the end of experiment. Serum insulin, total cholesterol (TC), LDL-C, HDL-C, TG, malondialdehyde (MDA), and total antioxidant capacity (TOAC) biomarker of oxidative stress were determined at the end of experiment. Results: All treatments resulted in a decrease in glucose and HbA1C compared to pretreatment. No difference in insulin concentration was observed. Serum TC was reduced by (T), while LDL-C decreased with (T) and (T+P) treatments. HDL-C was elevated with all treatments compared to control and (OHA) groups. MDA decreased with all treatments. TOAC was elevated with (T) and (T+P) but not with (P) treatment. Conclusion: Administration of Turmeric, Probiotics, and T+P combination were capable in attenuating hyperglycemia, dyslipidemia and oxidative stress initiated by STZ. However, (T) and (T+P) exerted a more potent hypolipidemic, and antioxidative effect compared to (P) alone.

Published in	American Journal of Biomedical and Life Sciences (Volume 1, Issue 1)
DOI	10.11648/j.ajbls.20130101.11
Page(s)	1-7
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2013. Published by Science Publishing Group

Keywords

Diabetes, Oxidative Stress, Probiotics, Curcumin, Supplement

References

[1]	Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C, Muscogiuri G The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. 2011; 7(5): 313-24.
[2]	Kempaiah RK, Srinivasan K. Beneficial influence of dietary curcumin, capsaicin and garlic on erythrocyte integrity in high-fat fed rats. J Nutr Biochem. 2006; 17(7) 471– 478.
[3]	Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004; 44(2): 97-111.
[4]	Pari L, Murugan P. Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic Clin Physiol Pharmacol 2005; 16: 257–274.
[5]	Rungseesantivanon S, Thenchaisri N, Ruangvejvorachai P, Patumraj S. Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complement Altern Med. 2010; 10: 57-62.
[6]	Babu SP, Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric Curcuma longa in streptozotocin induced diabetic rats. Mol and Cellular Biochem. 1997; 166: 169–175.
[7]	Srinivasan K, Manjunatha H. Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat–fed rats. Can J Physiol Pharmacol 2007; 85:588-96.
[8]	Eshrat HM, Hussain A. Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from CURCUMA LONGA and partially purified product from ABROMA AUGUSTA, in Streptozotocin induced diabetes. Indian J Clin Biochem. 2002; 17 (2): 33-43.
[9]	Kempaiah RK, Srinivasan K. Influence of dietary curcumin, capsaicin and garlic on the antioxidant status of red blood cells and the liver in high-fat-fed rats. Ann Nutr Metab. 2004; 48(5): 314-20.
[10]	Jang E-M, Choi M-S, Jung UJ, Kim M-J, Kim H-J, Jeon S-M, et al. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat–fed hamsters. Metab Clin and Exp. 2008; 57: 1576–1583.
[11]	Iannitti T, Palmieri B.Therapeutical use of probiotic formulations in clinical practice.Clin Nutr. 2010; 29(6):701-25.
[12]	Nagpal R, Yadav H, Puniya AK, Singh K, Jain S, Marotta F. Potential of probiotics and prebiotics for synbiotic functional dairy foods. Int. J Probiotics and Prebiotics 2007; 2:75–84.
[13]	Sanders TAB. Food production and food safety. BMJ 1999; 318(7199):1689–1693.
[14]	Nagpal R, Behare PV, Kumar M, et al. Milk, milk products and disease free health: an updated overview. Crit Rev Food Sci and Nutr 2011; 52(4):1549–52.
[15]	Pereira DIA, Gibson GR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem and Mol Biol 2002; 37(4):259–281.
[16]	Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009; 15(13): 1546-58.
[17]	Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results, J Diabetes Sci Technol. 2009; 3: 971-980.
[18]	Nuttall FQ (1998) Comparison of percent total GHb with percent HbA1c in people with and without known diabetes. Diabetes Care 1998; 21(9):1475-80.
[19]	SchettlerG, Nussel E. Enzymatic calorimetric determination of high density lipoprotein cholesterol by CHOD-PAP method, Arb. Med Soz. Med Prov Med. 1975;10:25.
[20]	Izawa S, Okada M, Matsui H, Horita Y. A new direct method for measuring HDL cholesterol which does not produce any biased values, J. Med. Pharm. Sci 1997; l37:1385-1388.
[21]	Fassati P, Prencipe L. Triglyceride enzymatic colorimetric method. Clin Chem 1982; 28: 2077.
[22]	Friedewald, W.T., Levy, R.I., Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18 (6): 499– 502.
[23]	Ohkawa, H., Ohishi, N., & Yagi, K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Analytical Biochemistry 1979; 95(2): 351–58.
[24]	Koracevic, D; Koracevic, G; Djordjevic, V; Andrejevic, S; Cosic, V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001; 54; 5 : 356-61.
[25]	Eastham RD. Biochemical values in clinical medicine. 7th ed. Bristol, England John Wright & Sons Ltd. (1985)
[26]	Pari L, Murugan P. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail. 2007; 29(7): 881-9.
[27]	Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105-25.
[28]	Fujiwara H, Hosokawa M, Zhou X, Fujimoto S, Fukuda K, Toyoda K, et al. Curcumin inhibits glucose production in isolated mice Hepatocytes. Diabetes Res and Clin Pract. 2008; 80:185-91.
[29]	Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr. 2011; 50(3):151-61.
[30]	Al-Salami H, Butt G, Fawcett JP, Tucker IG, Golocorbin-Kon S, Mikov M. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur J Drug Metab Pharmacokinet. 2008; 33(2):101-6.
[31]	Soudamini KK, Unnikrishnan MC, Soni KB, Kuttan R. Inhibition of lipid
[32]	peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol. 1992; 36:239–43.
[33]	Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit. 2005; 11:BR228–34.
[34]	Ramirez-Tortosa MC, Mesa MD, Aguilera MC, Quiles JL, Baro L. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 1999; 147:371–8.
[35]	Usman HA. Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains. J Dairy Sci. 1999; 82(2):243–248.
[36]	Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr. 2010; 103(12):1778-83.
[37]	Meghana K, Sanjeev G, Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: A prophylactic and protective role. European J Pharm. 2007; 577: 183–191.
[38]	Sundaram, R.K., Bhaskar, A., Vijayalingam, S., Viswanatthan, M., Moha, R., Shanmugasundaram, K.R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci. 1996; 90, 255–60.
[39]	Murugan P, Pari L. Antioxidant effect of tetrahydrocurcumin in streptozotocin–nicotinamide induced diabetic rats. Life Sciences 2006; 79:1720–1728.
[40]	Al-Suhaimi EA, Al-Riziza NA, Al-Essa RA. Physiological and therapeutical roles of ginger and turmeric on endocrine functions. Am J Chin Med. 2011; 39(2):215-31.
[41]	Fabian E, Elmadfa I. The effect of daily consumption of probiotic and conventional yoghurt on oxidant and anti-oxidant parameters in plasma of young healthy women. Int J Vitam Nutr Res. 2007; 77(2):79-88.

Cite This Article

Plain Text BibTeX RIS

APA Style

Badkook Maha. (2013). Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats. American Journal of Biomedical and Life Sciences, 1(1), 1-7. https://doi.org/10.11648/j.ajbls.20130101.11

Copy | Download

ACS Style

Badkook Maha. Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats. Am. J. Biomed. Life Sci. 2013, 1(1), 1-7. doi: 10.11648/j.ajbls.20130101.11

Copy | Download

AMA Style

Badkook Maha. Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats. Am J Biomed Life Sci. 2013;1(1):1-7. doi: 10.11648/j.ajbls.20130101.11

Copy | Download

@article{10.11648/j.ajbls.20130101.11,
  author = {Badkook Maha},
  title = {Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats},
  journal = {American Journal of Biomedical and Life Sciences},
  volume = {1},
  number = {1},
  pages = {1-7},
  doi = {10.11648/j.ajbls.20130101.11},
  url = {https://doi.org/10.11648/j.ajbls.20130101.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20130101.11},
  abstract = {Purpose: To investigate the effect of turmeric supplement (T), fermented milk with Probiotic strain Bifidobacterium lactis DN-173 010 (P), a combination of (T+P) on glycemia, lipidemia, and oxidative status in streptozotocin–induced diabetic rats.Materials and methods: Thirty male albino diabetic rats were fed a normal diet and divided to groups (n=6/group) according to the following treatments for 45 days: Turmeric (T) (225mg/kg/d), fermented milk Probiotics (P) (0.5ml/kg/d), Turmeric-Probiotics combination (T+ P) (225mg/kg/d + 0.5ml/kg/d), Oral hypoglycemic agent (OHA) (0.5 ml of glibenclamide; 450 µg/kg/day), and non-treated (DM). Blood glucose and glycayted hemoglobin were determined after diabetes induction and at the end of experiment. Serum insulin, total cholesterol (TC), LDL-C, HDL-C, TG, malondialdehyde (MDA), and total antioxidant capacity (TOAC) biomarker of oxidative stress were determined at the end of experiment. Results: All treatments resulted in a decrease in glucose and HbA1C compared to pretreatment. No difference in insulin concentration was observed. Serum TC was reduced by (T), while LDL-C decreased with (T) and (T+P) treatments. HDL-C was elevated with all treatments compared to control and (OHA) groups. MDA decreased with all treatments. TOAC was elevated with (T) and (T+P) but not with (P) treatment. Conclusion: Administration of Turmeric, Probiotics, and T+P combination were capable in attenuating hyperglycemia, dyslipidemia and oxidative stress initiated by STZ. However, (T) and (T+P) exerted a more potent hypolipidemic, and antioxidative effect compared to (P) alone.},
 year = {2013}
}

Copy | Download

TY  - JOUR
T1  - Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats
AU  - Badkook Maha
Y1  - 2013/05/30
PY  - 2013
N1  - https://doi.org/10.11648/j.ajbls.20130101.11
DO  - 10.11648/j.ajbls.20130101.11
T2  - American Journal of Biomedical and Life Sciences
JF  - American Journal of Biomedical and Life Sciences
JO  - American Journal of Biomedical and Life Sciences
SP  - 1
EP  - 7
PB  - Science Publishing Group
SN  - 2330-880X
UR  - https://doi.org/10.11648/j.ajbls.20130101.11
AB  - Purpose: To investigate the effect of turmeric supplement (T), fermented milk with Probiotic strain Bifidobacterium lactis DN-173 010 (P), a combination of (T+P) on glycemia, lipidemia, and oxidative status in streptozotocin–induced diabetic rats.Materials and methods: Thirty male albino diabetic rats were fed a normal diet and divided to groups (n=6/group) according to the following treatments for 45 days: Turmeric (T) (225mg/kg/d), fermented milk Probiotics (P) (0.5ml/kg/d), Turmeric-Probiotics combination (T+ P) (225mg/kg/d + 0.5ml/kg/d), Oral hypoglycemic agent (OHA) (0.5 ml of glibenclamide; 450 µg/kg/day), and non-treated (DM). Blood glucose and glycayted hemoglobin were determined after diabetes induction and at the end of experiment. Serum insulin, total cholesterol (TC), LDL-C, HDL-C, TG, malondialdehyde (MDA), and total antioxidant capacity (TOAC) biomarker of oxidative stress were determined at the end of experiment. Results: All treatments resulted in a decrease in glucose and HbA1C compared to pretreatment. No difference in insulin concentration was observed. Serum TC was reduced by (T), while LDL-C decreased with (T) and (T+P) treatments. HDL-C was elevated with all treatments compared to control and (OHA) groups. MDA decreased with all treatments. TOAC was elevated with (T) and (T+P) but not with (P) treatment. Conclusion: Administration of Turmeric, Probiotics, and T+P combination were capable in attenuating hyperglycemia, dyslipidemia and oxidative stress initiated by STZ. However, (T) and (T+P) exerted a more potent hypolipidemic, and antioxidative effect compared to (P) alone.
VL  - 1
IS  - 1
ER  -

Copy | Download

Author Information

Badkook Maha

Department of Food and Nutrition, King AbdulAziz University, Jeddah, Saudi Arabia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Badkook Maha. (2013). Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats. American Journal of Biomedical and Life Sciences, 1(1), 1-7. https://doi.org/10.11648/j.ajbls.20130101.11

Copy | Download

ACS Style

Badkook Maha. Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats. Am. J. Biomed. Life Sci. 2013, 1(1), 1-7. doi: 10.11648/j.ajbls.20130101.11

Copy | Download

AMA Style

Badkook Maha. Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats. Am J Biomed Life Sci. 2013;1(1):1-7. doi: 10.11648/j.ajbls.20130101.11

Copy | Download

@article{10.11648/j.ajbls.20130101.11,
  author = {Badkook Maha},
  title = {Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats},
  journal = {American Journal of Biomedical and Life Sciences},
  volume = {1},
  number = {1},
  pages = {1-7},
  doi = {10.11648/j.ajbls.20130101.11},
  url = {https://doi.org/10.11648/j.ajbls.20130101.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20130101.11},
  abstract = {Purpose: To investigate the effect of turmeric supplement (T), fermented milk with Probiotic strain Bifidobacterium lactis DN-173 010 (P), a combination of (T+P) on glycemia, lipidemia, and oxidative status in streptozotocin–induced diabetic rats.Materials and methods: Thirty male albino diabetic rats were fed a normal diet and divided to groups (n=6/group) according to the following treatments for 45 days: Turmeric (T) (225mg/kg/d), fermented milk Probiotics (P) (0.5ml/kg/d), Turmeric-Probiotics combination (T+ P) (225mg/kg/d + 0.5ml/kg/d), Oral hypoglycemic agent (OHA) (0.5 ml of glibenclamide; 450 µg/kg/day), and non-treated (DM). Blood glucose and glycayted hemoglobin were determined after diabetes induction and at the end of experiment. Serum insulin, total cholesterol (TC), LDL-C, HDL-C, TG, malondialdehyde (MDA), and total antioxidant capacity (TOAC) biomarker of oxidative stress were determined at the end of experiment. Results: All treatments resulted in a decrease in glucose and HbA1C compared to pretreatment. No difference in insulin concentration was observed. Serum TC was reduced by (T), while LDL-C decreased with (T) and (T+P) treatments. HDL-C was elevated with all treatments compared to control and (OHA) groups. MDA decreased with all treatments. TOAC was elevated with (T) and (T+P) but not with (P) treatment. Conclusion: Administration of Turmeric, Probiotics, and T+P combination were capable in attenuating hyperglycemia, dyslipidemia and oxidative stress initiated by STZ. However, (T) and (T+P) exerted a more potent hypolipidemic, and antioxidative effect compared to (P) alone.},
 year = {2013}
}

Copy | Download

TY  - JOUR
T1  - Antidiabetic Potential of Turmeric with/without Fermented Milk Enriched with Probiotics in Diabetic Rats
AU  - Badkook Maha
Y1  - 2013/05/30
PY  - 2013
N1  - https://doi.org/10.11648/j.ajbls.20130101.11
DO  - 10.11648/j.ajbls.20130101.11
T2  - American Journal of Biomedical and Life Sciences
JF  - American Journal of Biomedical and Life Sciences
JO  - American Journal of Biomedical and Life Sciences
SP  - 1
EP  - 7
PB  - Science Publishing Group
SN  - 2330-880X
UR  - https://doi.org/10.11648/j.ajbls.20130101.11
AB  - Purpose: To investigate the effect of turmeric supplement (T), fermented milk with Probiotic strain Bifidobacterium lactis DN-173 010 (P), a combination of (T+P) on glycemia, lipidemia, and oxidative status in streptozotocin–induced diabetic rats.Materials and methods: Thirty male albino diabetic rats were fed a normal diet and divided to groups (n=6/group) according to the following treatments for 45 days: Turmeric (T) (225mg/kg/d), fermented milk Probiotics (P) (0.5ml/kg/d), Turmeric-Probiotics combination (T+ P) (225mg/kg/d + 0.5ml/kg/d), Oral hypoglycemic agent (OHA) (0.5 ml of glibenclamide; 450 µg/kg/day), and non-treated (DM). Blood glucose and glycayted hemoglobin were determined after diabetes induction and at the end of experiment. Serum insulin, total cholesterol (TC), LDL-C, HDL-C, TG, malondialdehyde (MDA), and total antioxidant capacity (TOAC) biomarker of oxidative stress were determined at the end of experiment. Results: All treatments resulted in a decrease in glucose and HbA1C compared to pretreatment. No difference in insulin concentration was observed. Serum TC was reduced by (T), while LDL-C decreased with (T) and (T+P) treatments. HDL-C was elevated with all treatments compared to control and (OHA) groups. MDA decreased with all treatments. TOAC was elevated with (T) and (T+P) but not with (P) treatment. Conclusion: Administration of Turmeric, Probiotics, and T+P combination were capable in attenuating hyperglycemia, dyslipidemia and oxidative stress initiated by STZ. However, (T) and (T+P) exerted a more potent hypolipidemic, and antioxidative effect compared to (P) alone.
VL  - 1
IS  - 1
ER  -

Copy | Download